Navigation Links
Vaccines Might Become Another Way to Fight Cancer
Date:1/18/2013

brain cancer, called glioblastomas. Their vaccine, like the approved prostate cancer vaccine, uses the patient's own cancer cells to develop a unique vaccine specific to that person's cancer.

"The five-year survival is less than 5 percent for glioblastoma, and the average survival is about two years," Liau said. "We have several patients that are at eight and 10 years, and one who's at 12 years, but not everybody responds. One thing we have found is there are probably certain genetic subtypes that are more amenable to [vaccines]."

It's just those types of genetic differences that Hardacre said will probably keep researchers from being able to develop a universal cancer vaccine.

"I would find it hard to believe that there could be a single vaccine to deal with multiple types of cancers," he said.

More information

For more about cancer vaccines, go to the U.S. National Cancer Institute.

Read about the development of cervical cancer vaccines.

SOURCES: Jeffrey Hardacre, M.D., associate professor, surgery, and section head, pancreatic surgery, Seidman Cancer Center, University Hospitals, Case Western Reserve University, Cleveland, Ohio; Linda Liau, M.D., professor, neurosurgery, and director, brain tumor program, University of California, Los Angeles


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
2. World Health Assembly endorses new plan to increase global access to vaccines
3. OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
4. Control gene for conveyor belt cells could help improve oral vaccines, treat intestinal disease
5. ACP Immunization Advisor app makes it easier for doctors to identify vaccines for patients
6. Antibodies for new rotavirus vaccines
7. Scientists explore new class of synthetic vaccines
8. Sleep affects potency of vaccines
9. Kindergarten Vaccines Close to Target Levels: CDC
10. Cancer vaccine Special Focus series published in Human Vaccines & Immunotherapeutics
11. Mans best friend: Common canine virus may lead to new vaccines for deadly human diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vaccines Might Become Another Way to Fight Cancer
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... N.J. (September 9, 2010) Researchers from the John Theurer ... role in a study that led to the Food & ... treatment for metastatic melanoma. The FDA based its decision largely ... New England Journal of Medicine on August 19, ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Sept. 9 ... goals for the amount of fruit and vegetables people should ... not even close to reaching those thresholds, health officials said ... Disease Control and Prevention, in 2009, 67.5 percent of adults ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, Sept. ... obesity throughout your life: Doing so may improve your chances of ... who are obese and diagnosed with colon cancer appear to face ... are at a healthy weight or merely overweight, a new study ...
... (NEEM) will open tomorrow in Riga, Latvia with prostate, ... the two-day meeting. "The discussion will focus on ... will present updates on a variety of subjects such ... results in radical prostatectomy, treatment options in high-risk non ...
... This release is available in French . ... published in The Journal of Sexual Medicine has ... sympathy to women,s chronic vulvovaginal pain may trigger more pain, ... Women who took part in the study, conducted by the ...
... News media and others interested in the chemical sciences ... of American Chemical Society (ACS) Webinars, focusing on how ... funding programs. Scheduled for Thursday, Sept. 16, from ... will feature Josephine Yuen, Ph.D., NSF Program Director, speaking ...
Cached Medicine News:Health News:Promising treatment for metastatic melanoma 'fast tracked' by FDA 2Health News:Promising treatment for metastatic melanoma 'fast tracked' by FDA 3Health News:Most Americans Still Not Eating Enough Fruits, Veggies 2Health News:Most Americans Still Not Eating Enough Fruits, Veggies 3Health News:Obesity May Up Death Risk in Older Women With Colon Cancer 2Health News:Obesity May Up Death Risk in Older Women With Colon Cancer 3Health News:Romantic partner may play role in reducing vulvovaginal pain 2Health News:American Chemical Society Webinar focuses on NSF's small business funding programs 2
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... Directors has approved a share repurchase program. The open-ended ... million of Mallinckrodt plc ordinary shares. ... remain top priorities as we continue to pursue a ...
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... sodium injection) were also ... within 90 days-, BRIDGEWATER, N.J., Dec 10 ... total hospital,direct medical costs associated with VTE treatment are ... the use of low-molecular weight heparin,(LMWH) vs. unfractionated heparin ...
... 10 Alfacell Corporation,(Nasdaq: ACEL ) today reported ... The company recorded a net loss of approximately ... for the fiscal quarter ended Oct. 31,compared to a ... and diluted,common share, for the first quarter of fiscal ...
Cached Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Alfacell Reports Financial Results for First Quarter of Fiscal 2008 2Alfacell Reports Financial Results for First Quarter of Fiscal 2008 3Alfacell Reports Financial Results for First Quarter of Fiscal 2008 4Alfacell Reports Financial Results for First Quarter of Fiscal 2008 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: